TABLE 3.
Distribution of macrolide resistance genotypes of clinical pneumococcal isolates in 11 centers from seven European countries
| Country | Center | No. of strains |
mef(A) positive
|
erm(B) positive
|
||
|---|---|---|---|---|---|---|
| No. | % | No. | % | |||
| France | Paris | 20 | 4 | 20.0 | 16 | 80.0 |
| France | Lyon | 5 | 1 | 20.0 | 4 | 80.0 |
| France | Lille | 12 | 0 | 0.0 | 12 | 100.0 |
| France | Total | 37 | 5 | 13.5 | 32 | 87.5 |
| Spain | Madrid | 11 | 2 | 18.2 | 9 | 81.8 |
| Spain | Seville | 3 | 0 | 0.0 | 3 | 100.0 |
| Spain | Barcelona | 8 | 3 | 37.5 | 5 | 62.5 |
| Spain | Total | 22 | 5 | 22.7 | 17 | 77.3 |
| Greece | Athens | 4 | 4 | 100.0 | 0 | 0.0 |
| Portugal | Coimbra | 1 | 1 | 100.0 | 0 | 0.0 |
| Germany | Düsseldorf | 3 | 1 | 33.3 | 2 | 66.7 |
| Switzerland | Lausanne | 10 | 2 | 20.0 | 8 | 80.0 |
| Poland | Warsaw | 5 | 0 | 0.0 | 5 | 100.0 |
| Total | 82 | 18 | 22.0 | 64 | 78.0 | |